Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

Clinical Data for OrbusNeich's COMBO™Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013 PR Newswire HONG KONG, Oct. 22, 2013 -- Company's Scoreflex™ Coronary Dilatation Catheter and Pro-Healing Drug Eluting Bioresorbable Scaffold Will Also Be Featured OrbusNeich today announced that clinical data for the COMBO Dual Therapy Stent will be presented at Transcatheter Cardiovascular Therapeutics (TCT) 2013, Oct. 27-Nov. 1, in San Francisco. The scientific sessions will feature results from the EGO-COMBO Study assessing the healing profile of COMBO by optical coherence tomography (OCT) and results from the REMEDEE Study, a randomized trial of COMBO versus DES. Clinical data for COMBO will also be presented during a lunch symposium entitled "The COMBO Dual Therapy Stent – Setting the New Standard of Stenting" on Thursday, Oct. 31. In addition, OrbusNeich's Scoreflex Coronary Dilatation Catheter will be featured in a challenging case presentation, and a development update for the company's pro-healing drug eluting bioresorbable scaffold will be included in a session on emerging devices. Sunday, Oct. 27 Oral Sessions • Shigeru Saito, M.D., of the Shonan Kamakura General Hospital, Japan, will present "EPC Capture, Bioabsorbable Polymer Sirolimus DES: The Japan-US COMBO Study Plan" at 1:10 p.m. PDT in Room 238 (Moscone South, West Mezzanine). • Michael Haude, M.D.